{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:01:42Z","timestamp":1793908902918,"version":"4.8.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100005440","name":"Center for Scientific Review","doi-asserted-by":"publisher","award":["R01 AR074939, R01 AR081654, R01 AI186337, R21 AR077266, T32 AR007108, K08 AR082939"],"award-info":[{"award-number":["R01 AR074939, R01 AR081654, R01 AI186337, R21 AR077266, T32 AR007108, K08 AR082939"]}],"id":[{"id":"10.13039\/100005440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kyowa Kirin Inc. (KKNA) Accelerator Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mobile DNA"],"DOI":"10.1186\/s13100-025-00371-y","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:47:31Z","timestamp":1759236451000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Type I interferons increase expression of endogenous retrovirus K102 and envelope protein in myeloid cells from patients with autoimmune disease"],"prefix":"10.1186","volume":"16","author":[{"given":"Ethan","family":"Le","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Moadab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayan","family":"Najjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Bays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Hastie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Shek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica Ollmann","family":"Saphire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Mustelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"9","key":"371_CR1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1056\/NEJM197608262950903","volume":"295","author":"S Panem","year":"1976","unstructured":"Panem S, Ordonez NG, Kirstein WH, Katz AI, Spargo BH. C-type virus expression in systemic lupus erythematosus. N Engl J Med. 1976;295(9):470\u20135.","journal-title":"N Engl J Med"},{"issue":"1","key":"371_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1073\/pnas.73.1.233","volume":"73","author":"RC Mellors","year":"1976","unstructured":"Mellors RC, Mellors JW. Antigen related to mammalian type-C RNA viral p30 proteins is located in renal glomeruli in human systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1976;73(1):233\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"371_CR3","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1136\/ard.38.6.514","volume":"38","author":"H Hart","year":"1979","unstructured":"Hart H, McCormick JN, Marmion BP. Viruses and lymphocytes in rheumatoid arthritis. II. Examination of lymphocytes and sera from patients with rheumatoid arthritis for evidence of retrovirus infection. Ann Rheum Dis. 1979;38(6):514\u201325.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"371_CR4","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/ard.44.11.761","volume":"44","author":"E Rodahl","year":"1985","unstructured":"Rodahl E, Iversen OJ. Antigens related to the major internal protein, p27, of a psoriasis associated retrovirus-like particle are expressed in patients with chronic arthritis. Ann Rheum Dis. 1985;44(11):761\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"371_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1365-3083.1988.tb02431.x","volume":"28","author":"K Asbakk","year":"1988","unstructured":"Asbakk K, Iversen OJ. Monoclonal antibodies against the major internal protein, p27, of a psoriasis-associated retrovirus-like particle. Scand J Immunol. 1988;28(2):195\u2013202.","journal-title":"Scand J Immunol"},{"issue":"10","key":"371_CR6","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/art.1780341022","volume":"34","author":"H Dang","year":"1991","unstructured":"Dang H, Dauphinee MJ, Talal N, Garry RF, Seibold JR, Medsger TA Jr, et al. Serum antibody to retroviral gag proteins in systemic sclerosis. Arthritis Rheum. 1991;34(10):1336\u20137.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"371_CR7","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1172\/JCI114647","volume":"85","author":"N Talal","year":"1990","unstructured":"Talal N, Garry RF, Schur PH, Alexander S, Dauphinee MJ, Livas IH, et al. A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus. J Clin Invest. 1990;85(6):1866\u201371.","journal-title":"J Clin Invest"},{"issue":"6","key":"371_CR8","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/art.1780330603","volume":"33","author":"N Talal","year":"1990","unstructured":"Talal N, Dauphinee MJ, Dang H, Alexander SS, Hart DJ, Garry RF. Detection of serum antibodies to retroviral proteins in patients with primary Sjogren\u2019s syndrome (autoimmune exocrinopathy). Arthritis Rheum. 1990;33(6):774\u201381.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"371_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/art.1780370109","volume":"37","author":"J Blomberg","year":"1994","unstructured":"Blomberg J, Nived O, Pipkorn R, Bengtsson A, Erlinge D, Sturfelt G. Increased antiretroviral antibody reactivity in sera from a defined population of patients with systemic lupus erythematosus. Correlation with autoantibodies and clinical manifestations. Arthritis Rheum. 1994;37(1):57\u201366.","journal-title":"Arthritis Rheum"},{"key":"371_CR10","doi-asserted-by":"crossref","unstructured":"Perl A, Colombo E, Dai H, Agarwal R, Mark KA, Banki K, et al. Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes. Correlation with antinuclear antibodies and HLA class II alleles. Arthritis Rheum. 1995;38(11):1660\u201371.","DOI":"10.1002\/art.1780381119"},{"issue":"5","key":"371_CR11","first-page":"479","volume":"37","author":"KY Fong","year":"1996","unstructured":"Fong KY, Boey ML, Yuen M, Nadarajah M, Feng PH. Absence of retroviral antibodies in the sera of patients with systemic lupus erythematosus. Singapore Med J. 1996;37(5):479\u201381.","journal-title":"Singapore Med J"},{"issue":"Suppl 1","key":"371_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3109\/10428199309047874","volume":"11","author":"I Brodsky","year":"1993","unstructured":"Brodsky I, Foley B, Gillespie D. Expression of human endogenous retrovirus (HERV-K) in chronic myeloid leukemia. Leuk Lymphoma. 1993;11(Suppl 1):119\u201323.","journal-title":"Leuk Lymphoma"},{"issue":"24","key":"371_CR13","doi-asserted-by":"publisher","first-page":"5211","DOI":"10.1093\/nar\/22.24.5211","volume":"22","author":"M Tassabehji","year":"1994","unstructured":"Tassabehji M, Strachan T, Anderson M, Campbell RD, Collier S, Lako M. Identification of a novel family of human endogenous retroviruses and characterization of one family member, HERV-K(C4), located in the complement C4 gene cluster. Nucleic Acids Res. 1994;22(24):5211\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"371_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S1016-8478(23)17074-9","volume":"12","author":"JM Yi","year":"2001","unstructured":"Yi JM, Kim HM, Kim HS. Molecular cloning and phylogenetic analysis of the human endogenous retrovirus HERV-K long terminal repeat elements in various cancer cells. Mol Cells. 2001;12(1):137\u201341.","journal-title":"Mol Cells"},{"issue":"6822","key":"371_CR15","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/35057062","volume":"409","author":"ES Lander","year":"2001","unstructured":"Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409(6822):860\u2013921.","journal-title":"Nature"},{"issue":"12","key":"371_CR16","doi-asserted-by":"publisher","first-page":"9782","DOI":"10.1128\/JVI.72.12.9782-9787.1998","volume":"72","author":"P Medstrand","year":"1998","unstructured":"Medstrand P, Mager DL. Human-specific integrations of the HERV-K endogenous retrovirus family. J Virol. 1998;72(12):9782\u20137.","journal-title":"J Virol"},{"issue":"6134","key":"371_CR17","first-page":"820","volume":"340","author":"RA Weiss","year":"2013","unstructured":"Weiss RA, Stoye JP. Virology. Our viral inheritance Science. 2013;340(6134):820\u20131.","journal-title":"Our viral inheritance Science"},{"key":"371_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1742-4690-8-90","volume":"8","author":"RP Subramanian","year":"2011","unstructured":"Subramanian RP, Wildschutte JH, Russo C, Coffin JM. Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses. Retrovirology. 2011;8:90.","journal-title":"Retrovirology"},{"issue":"16","key":"371_CR19","doi-asserted-by":"publisher","first-page":"E2326","DOI":"10.1073\/pnas.1602336113","volume":"113","author":"JH Wildschutte","year":"2016","unstructured":"Wildschutte JH, Williams ZH, Montesion M, Subramanian RP, Kidd JM, Coffin JM. Discovery of unfixed endogenous retrovirus insertions in diverse human populations. Proc Natl Acad Sci U S A. 2016;113(16):E2326\u201334.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"371_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1006\/geno.1993.1464","volume":"18","author":"C Leib-Mosch","year":"1993","unstructured":"Leib-Mosch C, Haltmeier M, Werner T, Geigl EM, Brack-Werner R, Francke U, et al. Genomic distribution and transcription of solitary HERV-K LTRs. Genomics. 1993;18(2):261\u20139.","journal-title":"Genomics"},{"issue":"1\u20132","key":"371_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/apm.12475","volume":"124","author":"K Hanke","year":"2016","unstructured":"Hanke K, Hohn O, Bannert N. HERV-K(HML-2), a seemingly silent subtenant - but still waters run deep. APMIS. 2016;124(1\u20132):67\u201387.","journal-title":"APMIS"},{"key":"371_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12977-015-0136-x","volume":"12","author":"G Magiorkinis","year":"2015","unstructured":"Magiorkinis G, Blanco-Melo D, Belshaw R. The decline of human endogenous retroviruses: extinction and survival. Retrovirology. 2015;12:8.","journal-title":"Retrovirology"},{"key":"371_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.virol.2015.10.014","volume":"487","author":"P Kramer","year":"2016","unstructured":"Kramer P, Lausch V, Volkwein A, Hanke K, Hohn O, Bannert N. The human endogenous retrovirus K(HML-2) has a broad envelope-mediated cellular tropism and is prone to inhibition at a post-entry, pre-integration step. Virology. 2016;487:121\u20138.","journal-title":"Virology"},{"issue":"Pt 2","key":"371_CR24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1099\/vir.0.83534-0","volume":"89","author":"K Boller","year":"2008","unstructured":"Boller K, Schonfeld K, Lischer S, Fischer N, Hoffmann A, Kurth R, et al. Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles. J Gen Virol. 2008;89(Pt 2):567\u201372.","journal-title":"J Gen Virol"},{"issue":"2","key":"371_CR25","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1006\/viro.1996.0443","volume":"222","author":"GR Simpson","year":"1996","unstructured":"Simpson GR, Patience C, Lower R, Tonjes RR, Moore HD, Weiss RA, et al. Endogenous d-type (HERV-K) related sequences are packaged into retroviral particles in the placenta and possess open reading frames for reverse transcriptase. Virology. 1996;222(2):451\u20136.","journal-title":"Virology"},{"issue":"12","key":"371_CR26","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1101\/gr.5565706","volume":"16","author":"M Dewannieux","year":"2006","unstructured":"Dewannieux M, Harper F, Richaud A, Letzelter C, Ribet D, Pierron G, et al. Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements. Genome Res. 2006;16(12):1548\u201356.","journal-title":"Genome Res"},{"issue":"8","key":"371_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007123","volume":"14","author":"LR Robinson-McCarthy","year":"2018","unstructured":"Robinson-McCarthy LR, McCarthy KR, Raaben M, Piccinotti S, Nieuwenhuis J, Stubbs SH, et al. Reconstruction of the cell entry pathway of an extinct virus. PLoS Pathog. 2018;14(8):e1007123.","journal-title":"PLoS Pathog"},{"issue":"1","key":"371_CR28","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.virol.2007.09.036","volume":"371","author":"N Beimforde","year":"2008","unstructured":"Beimforde N, Hanke K, Ammar I, Kurth R, Bannert N. Molecular cloning and functional characterization of the human endogenous retrovirus K113. Virology. 2008;371(1):216\u201325.","journal-title":"Virology"},{"issue":"11","key":"371_CR29","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1089\/aid.2004.20.1223","volume":"20","author":"T Burmeister","year":"2004","unstructured":"Burmeister T, Ebert AD, Pritze W, Loddenkemper C, Schwartz S, Thiel E. Insertional polymorphisms of endogenous HERV-K113 and HERV-K115 retroviruses in breast cancer patients and age-matched controls. AIDS Res Hum Retroviruses. 2004;20(11):1223\u20139.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"5","key":"371_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020234","volume":"6","author":"AR Jha","year":"2011","unstructured":"Jha AR, Nixon DF, Rosenberg MG, Martin JN, Deeks SG, Hudson RR, et al. Human endogenous retrovirus K106 (HERV-K106) was infectious after the emergence of anatomically modern humans. PLoS One. 2011;6(5):e20234.","journal-title":"PLoS One"},{"key":"371_CR31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1742-4690-10-16","volume":"10","author":"M Manghera","year":"2013","unstructured":"Manghera M, Douville RN. Endogenous retrovirus-K promoter: a landing strip for inflammatory transcription factors? Retrovirology. 2013;10:16.","journal-title":"Retrovirology"},{"key":"371_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/v12080884","author":"FK Geis","year":"2020","unstructured":"Geis FK, Goff SP. Silencing and transcriptional regulation of endogenous retroviruses: an overview. Viruses. 2020. https:\/\/doi.org\/10.3390\/v12080884.","journal-title":"Viruses"},{"key":"371_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/v9060130","author":"TP Hurst","year":"2017","unstructured":"Hurst TP, Magiorkinis G. Epigenetic control of human endogenous retrovirus expression: focus on regulation of long-terminal repeats (LTRs). Viruses. 2017. https:\/\/doi.org\/10.3390\/v9060130.","journal-title":"Viruses"},{"issue":"7555","key":"371_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature14308","volume":"522","author":"EJ Grow","year":"2015","unstructured":"Grow EJ, Flynn RA, Chavez SL, Bayless NL, Wossidlo M, Wesche DJ, et al. Intrinsic retroviral reactivation in human preimplantation embryos and pluripotent cells. Nature. 2015;522(7555):221\u20135.","journal-title":"Nature"},{"issue":"10","key":"371_CR35","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1093\/carcin\/bgr181","volume":"32","author":"W Goering","year":"2011","unstructured":"Goering W, Ribarska T, Schulz WA. Selective changes of retroelement expression in human prostate cancer. Carcinogenesis. 2011;32(10):1484\u201392.","journal-title":"Carcinogenesis"},{"issue":"10","key":"371_CR36","doi-asserted-by":"publisher","first-page":"4172","DOI":"10.1158\/0008-5472.CAN-04-2983","volume":"65","author":"K Buscher","year":"2005","unstructured":"Buscher K, Trefzer U, Hofmann M, Sterry W, Kurth R, Denner J. Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. Cancer Res. 2005;65(10):4172\u201380.","journal-title":"Cancer Res"},{"issue":"19","key":"371_CR37","doi-asserted-by":"publisher","first-page":"11108","DOI":"10.1128\/JVI.01623-14","volume":"88","author":"N Bhardwaj","year":"2014","unstructured":"Bhardwaj N, Maldarelli F, Mellors J, Coffin JM. HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production. J Virol. 2014;88(19):11108\u201320.","journal-title":"J Virol"},{"issue":"17","key":"371_CR38","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1212\/WNL.0000000000003258","volume":"87","author":"LN Bowen","year":"2016","unstructured":"Bowen LN, Tyagi R, Li W, Alfahad T, Smith B, Wright M, et al. HIV-associated motor neuron disease: HERV-K activation and response to antiretroviral therapy. Neurology. 2016;87(17):1756\u201362.","journal-title":"Neurology"},{"issue":"9","key":"371_CR39","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1089\/aid.2007.0054","volume":"23","author":"R Contreras-Galindo","year":"2007","unstructured":"Contreras-Galindo R, Almodovar-Camacho S, Gonzalez-Ramirez S, Lorenzo E, Yamamura Y. Comparative longitudinal studies of HERV-K and HIV-1 RNA titers in HIV-1-infected patients receiving successful versus unsuccessful highly active antiretroviral therapy. AIDS Res Hum Retroviruses. 2007;23(9):1083\u20136.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1\u20132","key":"371_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jviromet.2006.03.029","volume":"136","author":"R Contreras-Galindo","year":"2006","unstructured":"Contreras-Galindo R, Gonzalez M, Almodovar-Camacho S, Gonzalez-Ramirez S, Lorenzo E, Yamamura Y. A new real-time-RT-PCR for quantitation of human endogenous retroviruses type K (HERV-K) RNA load in plasma samples: increased HERV-K RNA titers in HIV-1 patients with HAART non-suppressive regimens. J Virol Methods. 2006;136(1\u20132):51\u20137.","journal-title":"J Virol Methods"},{"issue":"10","key":"371_CR41","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1089\/aid.2006.22.979","volume":"22","author":"R Contreras-Galindo","year":"2006","unstructured":"Contreras-Galindo R, Kaplan MH, Markovitz DM, Lorenzo E, Yamamura Y. Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals. AIDS Res Hum Retroviruses. 2006;22(10):979\u201384.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"371_CR42","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1089\/aid.2006.0117","volume":"23","author":"R Contreras-Galindo","year":"2007","unstructured":"Contreras-Galindo R, Lopez P, Velez R, Yamamura Y. HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro. AIDS Res Hum Retroviruses. 2007;23(1):116\u201322.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"371_CR43","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12977-017-0365-2","volume":"14","author":"M de Mulder","year":"2017","unstructured":"de Mulder M, SenGupta D, Deeks SG, Martin JN, Pilcher CD, Hecht FM, et al. Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers. Retrovirology. 2017;14(1):41.","journal-title":"Retrovirology"},{"issue":"1","key":"371_CR44","first-page":"16","volume":"33","author":"S Ehlhardt","year":"2006","unstructured":"Ehlhardt S, Seifert M, Schneider J, Ojak A, Zang KD, Mehraein Y. Human endogenous retrovirus HERV-K(HML-2) rec expression and transcriptional activities in normal and rheumatoid arthritis synovia. J Rheumatol. 2006;33(1):16\u201323.","journal-title":"J Rheumatol"},{"issue":"15","key":"371_CR45","doi-asserted-by":"publisher","first-page":"7790","DOI":"10.1128\/JVI.07215-11","volume":"86","author":"MJ Gonzalez-Hernandez","year":"2012","unstructured":"Gonzalez-Hernandez MJ, Swanson MD, Contreras-Galindo R, Cookinham S, King SR, Noel RJ Jr, et al. Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1. J Virol. 2012;86(15):7790\u2013805.","journal-title":"J Virol"},{"issue":"3","key":"371_CR46","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1365-3083.2009.02271.x","volume":"70","author":"F Reynier","year":"2009","unstructured":"Reynier F, Verjat T, Turrel F, Imbert PE, Marotte H, Mougin B, et al. Increase in human endogenous retrovirus HERV-K (HML-2) viral load in active rheumatoid arthritis. Scand J Immunol. 2009;70(3):295\u20139.","journal-title":"Scand J Immunol"},{"key":"371_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11051310","author":"A Laine","year":"2023","unstructured":"Laine A, Wang X, Ni K, Smith SEB, Najjar R, Whitmore LS, et al. Expression of envelope protein encoded by endogenous retrovirus K102 in rheumatoid arthritis neutrophils. Microorganisms. 2023. https:\/\/doi.org\/10.3390\/microorganisms11051310.","journal-title":"Microorganisms"},{"key":"371_CR48","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191766","author":"M Tokuyama","year":"2021","unstructured":"Tokuyama M, Gunn BM, Venkataraman A, Kong Y, Kang I, Rakib T, et al. Antibodies against human endogenous retrovirus K102 envelope activate neutrophils in systemic lupus erythematosus. J Exp Med. 2021. https:\/\/doi.org\/10.1084\/jem.20191766.","journal-title":"J Exp Med"},{"issue":"7","key":"371_CR49","first-page":"1306","volume":"40","author":"AI Khadjinova","year":"2022","unstructured":"Khadjinova AI, Wang X, Laine A, Ukadike K, Eckert M, Stevens A, et al. Autoantibodies against the envelope proteins of endogenous retroviruses K102 and K108 in patients with systemic lupus erythematosus correlate with active disease. Clin Exp Rheumatol. 2022;40(7):1306\u201312.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"371_CR50","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1046\/j.1365-2249.2002.01735.x","volume":"128","author":"CA Herve","year":"2002","unstructured":"Herve CA, Lugli EB, Brand A, Griffiths DJ, Venables PJ. Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes. Clin Exp Immunol. 2002;128(1):75\u201382.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"371_CR51","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/cei.12964","volume":"189","author":"G Mameli","year":"2017","unstructured":"Mameli G, Erre GL, Caggiu E, Mura S, Cossu D, Bo M, et al. Identification of a HERV-K env surface peptide highly recognized in Rheumatoid Arthritis (RA) patients: a cross-sectional case-control study. Clin Exp Immunol. 2017;189(1):127\u201331.","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"371_CR52","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.3899\/jrheum.130502","volume":"41","author":"PN Nelson","year":"2014","unstructured":"Nelson PN, Roden D, Nevill A, Freimanis GL, Trela M, Ejtehadi HD, et al. Rheumatoid arthritis is associated with IgG antibodies to human endogenous retrovirus gag matrix: a potential pathogenic mechanism of disease? J Rheumatol. 2014;41(10):1952\u201360.","journal-title":"J Rheumatol"},{"issue":"1","key":"371_CR53","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3899\/jrheum.201492","volume":"49","author":"X Wang","year":"2022","unstructured":"Wang X, Hefton A, Ni K, Ukadike KC, Bowen MA, Eckert M, et al. Autoantibodies against unmodified and citrullinated human endogenous retrovirus K envelope protein in patients with rheumatoid arthritis. J Rheumatol. 2022;49(1):26\u201335.","journal-title":"J Rheumatol"},{"issue":"5","key":"371_CR54","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1136\/ard.2004.031146","volume":"65","author":"HD Ejtehadi","year":"2006","unstructured":"Ejtehadi HD, Freimanis GL, Ali HA, Bowman S, Alavi A, Axford J, et al. The potential role of human endogenous retrovirus K10 in the pathogenesis of rheumatoid arthritis: a preliminary study. Ann Rheum Dis. 2006;65(5):612\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"371_CR55","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1365-2249.2010.04110.x","volume":"160","author":"G Freimanis","year":"2010","unstructured":"Freimanis G, Hooley P, Ejtehadi HD, Ali HA, Veitch A, Rylance PB, et al. A role for human endogenous retrovirus-K (HML-2) in rheumatoid arthritis: investigating mechanisms of pathogenesis. Clin Exp Immunol. 2010;160(3):340\u20137.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"371_CR56","doi-asserted-by":"publisher","first-page":"4940","DOI":"10.1038\/s41467-020-18761-6","volume":"11","author":"CH Douse","year":"2020","unstructured":"Douse CH, Tchasovnikarova IA, Timms RT, Protasio AV, Seczynska M, Prigozhin DM, et al. TASOR is a pseudo-PARP that directs HUSH complex assembly and epigenetic transposon control. Nat Commun. 2020;11(1):4940.","journal-title":"Nat Commun"},{"issue":"18","key":"371_CR57","doi-asserted-by":"publisher","first-page":"10313","DOI":"10.1093\/nar\/gkaa785","volume":"48","author":"DM Prigozhin","year":"2020","unstructured":"Prigozhin DM, Douse CH, Farleigh LE, Albecka A, Tchasovnikarova IA, Timms RT, et al. Periphilin self-association underpins epigenetic silencing by the HUSH complex. Nucleic Acids Res. 2020;48(18):10313\u201328.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"371_CR58","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1101\/gr.228171.117","volume":"28","author":"L Robbez-Masson","year":"2018","unstructured":"Robbez-Masson L, Tie CHC, Conde L, Tunbak H, Husovsky C, Tchasovnikarova IA, et al. The HUSH complex cooperates with TRIM28 to repress young retrotransposons and new genes. Genome Res. 2018;28(6):836\u201345.","journal-title":"Genome Res"},{"issue":"5","key":"371_CR59","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/BOR.0b013e32833c6297","volume":"22","author":"A Perl","year":"2010","unstructured":"Perl A, Fernandez D, Telarico T, Phillips PE. Endogenous retroviral pathogenesis in lupus. Curr Opin Rheumatol. 2010;22(5):483\u201392.","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"371_CR60","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04438-22","volume":"11","author":"E Russ","year":"2023","unstructured":"Russ E, Mikhalkevich N, Iordanskiy S. Expression of human endogenous retrovirus group K (HERV-K) HML-2 correlates with immune activation of macrophages and type i interferon response. Microbiol Spectr. 2023;11(2):e0443822.","journal-title":"Microbiol Spectr"},{"issue":"3","key":"371_CR61","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1128\/jvi.57.3.1119-1126.1986","volume":"57","author":"WL Hsiao","year":"1986","unstructured":"Hsiao WL, Gattoni-Celli S, Weinstein IB. Effects of 5-azacytidine on expression of endogenous retrovirus-related sequences in C3H 10T1\/2 cells. J Virol. 1986;57(3):1119\u201326.","journal-title":"J Virol"},{"issue":"4","key":"371_CR62","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/jhg.2013.140","volume":"59","author":"P Sukapan","year":"2014","unstructured":"Sukapan P, Promnarate P, Avihingsanon Y, Mutirangura A, Hirankarn N. Types of DNA methylation status of the interspersed repetitive sequences for LINE-1, Alu, HERV-E and HERV-K in the neutrophils from systemic lupus erythematosus patients and healthy controls. J Hum Genet. 2014;59(4):178\u201388.","journal-title":"J Hum Genet"},{"issue":"7646","key":"371_CR63","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nature21683","volume":"543","author":"M Imbeault","year":"2017","unstructured":"Imbeault M, Helleboid PY, Trono D. KRAB zinc-finger proteins contribute to the evolution of gene regulatory networks. Nature. 2017;543(7646):550\u20134.","journal-title":"Nature"},{"key":"371_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/v12080852","author":"CH Liu","year":"2020","unstructured":"Liu CH, Grandi N, Palanivelu L, Tramontano E, Lin LT. Contribution of human retroviruses to disease development-a focus on the HIV- and HERV-cancer relationships and treatment strategies. Viruses. 2020. https:\/\/doi.org\/10.3390\/v12080852.","journal-title":"Viruses"},{"issue":"5","key":"371_CR65","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/ijc.25760","volume":"129","author":"H Gross","year":"2011","unstructured":"Gross H, Barth S, Pfuhl T, Willnecker V, Spurk A, Gurtsevitch V, et al. The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2). Int J Cancer. 2011;129(5):1105\u201315.","journal-title":"Int J Cancer"},{"issue":"4","key":"371_CR66","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S1074-7613(01)00210-2","volume":"15","author":"N Sutkowski","year":"2001","unstructured":"Sutkowski N, Conrad B, Thorley-Lawson DA, Huber BT. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity. 2001;15(4):579\u201389.","journal-title":"Immunity"},{"issue":"12","key":"371_CR67","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.1172\/JCI64560","volume":"122","author":"RB Jones","year":"2012","unstructured":"Jones RB, Garrison KE, Mujib S, Mihajlovic V, Aidarus N, Hunter DV, et al. HERV-K-specific T cells eliminate diverse HIV-1\/2 and SIV primary isolates. J Clin Invest. 2012;122(12):4473\u201389.","journal-title":"J Clin Invest"},{"key":"371_CR68","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01507-17","author":"GR Young","year":"2018","unstructured":"Young GR, Terry SN, Manganaro L, Cuesta-Dominguez A, Deikus G, Bernal-Rubio D, et al. HIV-1 infection of primary CD4(+) T cells regulates the expression of specific human endogenous retrovirus HERV-K (HML-2) elements. J Virol. 2018. https:\/\/doi.org\/10.1128\/JVI.01507-17.","journal-title":"J Virol"},{"issue":"16","key":"371_CR69","doi-asserted-by":"publisher","first-page":"8924","DOI":"10.1128\/JVI.00556-14","volume":"88","author":"MJ Gonzalez-Hernandez","year":"2014","unstructured":"Gonzalez-Hernandez MJ, Cavalcoli JD, Sartor MA, Contreras-Galindo R, Meng F, Dai M, et al. Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 Tat protein. J Virol. 2014;88(16):8924\u201335.","journal-title":"J Virol"},{"issue":"1","key":"371_CR70","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12977-017-0351-8","volume":"14","author":"K Monde","year":"2017","unstructured":"Monde K, Terasawa H, Nakano Y, Soheilian F, Nagashima K, Maeda Y, et al. Molecular mechanisms by which HERV-K Gag interferes with HIV-1 Gag assembly and particle infectivity. Retrovirology. 2017;14(1):27.","journal-title":"Retrovirology"},{"issue":"1\u20132","key":"371_CR71","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0165-2478(95)00033-2","volume":"46","author":"W Vogetseder","year":"1995","unstructured":"Vogetseder W, Feng J, Dierich MP. Reactivity of monoclonal antibodies established against a recombinant human endogenous retrovirus-K (HERV-K) envelope protein. Immunol Lett. 1995;46(1\u20132):129\u201334.","journal-title":"Immunol Lett"},{"issue":"14","key":"371_CR72","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.1158\/0008-5472.CAN-07-6838","volume":"68","author":"F Wang-Johanning","year":"2008","unstructured":"Wang-Johanning F, Radvanyi L, Rycaj K, Plummer JB, Yan P, Sastry KJ, et al. Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients. Cancer Res. 2008;68(14):5869\u201377.","journal-title":"Cancer Res"},{"key":"371_CR73","unstructured":"Ng KW, Boumelha J, Enfield KSS, Almagro J, Cha H, Pich O. Antibodies against endogenous retroviruses promote lung cancer immunotherapy. Nature. 2023."},{"issue":"1","key":"371_CR74","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12977-018-0441-2","volume":"15","author":"M Montesion","year":"2018","unstructured":"Montesion M, Williams ZH, Subramanian RP, Kuperwasser C, Coffin JM. Promoter expression of HERV-K (HML-2) provirus-derived sequences is related to LTR sequence variation and polymorphic transcription factor binding sites. Retrovirology. 2018;15(1):57.","journal-title":"Retrovirology"},{"issue":"6","key":"371_CR75","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1128\/jvi.61.6.2059-2062.1987","volume":"61","author":"M Ono","year":"1987","unstructured":"Ono M, Kawakami M, Ushikubo H. Stimulation of expression of the human endogenous retrovirus genome by female steroid hormones in human breast cancer cell line T47D. J Virol. 1987;61(6):2059\u201362.","journal-title":"J Virol"},{"issue":"3","key":"371_CR76","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/ijc.28389","volume":"134","author":"F Wang-Johanning","year":"2014","unstructured":"Wang-Johanning F, Li M, Esteva FJ, Hess KR, Yin B, Rycaj K, et al. Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer. Int J Cancer. 2014;134(3):587\u201395.","journal-title":"Int J Cancer"},{"issue":"6277","key":"371_CR77","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1126\/science.aad5497","volume":"351","author":"EB Chuong","year":"2016","unstructured":"Chuong EB, Elde NC, Feschotte C. Regulatory evolution of innate immunity through co-option of endogenous retroviruses. Science. 2016;351(6277):1083\u20137.","journal-title":"Science"},{"issue":"1","key":"371_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s13100-023-00293-7","volume":"14","author":"KC Ukadike","year":"2023","unstructured":"Ukadike KC, Najjar R, Ni K, Laine A, Wang X, Bays A, et al. Expression of L1 retrotransposons in granulocytes from patients with active systemic lupus erythematosus. Mob DNA. 2023;14(1):5.","journal-title":"Mob DNA"},{"issue":"1","key":"371_CR79","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics"},{"issue":"22","key":"371_CR80","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1093\/bioinformatics\/btv422","volume":"31","author":"Y Jin","year":"2015","unstructured":"Jin Y, Tam OH, Paniagua E, Hammell M. TEtranscripts: a package for including transposable elements in differential expression analysis of RNA-seq datasets. Bioinformatics. 2015;31(22):3593\u20139.","journal-title":"Bioinformatics"},{"key":"371_CR81","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-61779-603-6_2","volume":"859","author":"S Tempel","year":"2012","unstructured":"Tempel S. Using and understanding repeatmasker. Methods Mol Biol. 2012;859:29\u201351.","journal-title":"Methods Mol Biol"},{"issue":"12","key":"371_CR82","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"}],"container-title":["Mobile DNA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13100-025-00371-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13100-025-00371-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13100-025-00371-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T01:05:14Z","timestamp":1759280714000},"score":1,"resource":{"primary":{"URL":"https:\/\/mobilednajournal.biomedcentral.com\/articles\/10.1186\/s13100-025-00371-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["371"],"URL":"https:\/\/doi.org\/10.1186\/s13100-025-00371-y","relation":{},"ISSN":["1759-8753"],"issn-type":[{"value":"1759-8753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the University of Washington Institutional Review Board. Informed written consent was obtained from all participants according to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TM reports consulting fees from Cugene, ROME Therapeutics, Evolved, and Codify Therapeutics.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}